Publication: Microbiology Investigation Criteria for Reporting Objectively (MICRO): A framework for the reporting and interpretation of clinical microbiology data
Issued Date
2019-03-29
Resource Type
ISSN
17417015
Other identifier(s)
2-s2.0-85063725062
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
BMC Medicine. Vol.17, No.1 (2019)
Suggested Citation
Paul Turner, Andrew Fox-Lewis, Poojan Shrestha, David A.B. Dance, Tri Wangrangsimakul, Tomas Paul Cusack, Clare L. Ling, Jill Hopkins, Tamalee Roberts, Direk Limmathurotsakul, Ben S. Cooper, Susanna Dunachie, Catrin E. Moore, Christiane Dolecek, H. Rogier Van Doorn, Philippe J. Guerin, Nicholas P.J. Day, Elizabeth A. Ashley Microbiology Investigation Criteria for Reporting Objectively (MICRO): A framework for the reporting and interpretation of clinical microbiology data. BMC Medicine. Vol.17, No.1 (2019). doi:10.1186/s12916-019-1301-1 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/51783
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Microbiology Investigation Criteria for Reporting Objectively (MICRO): A framework for the reporting and interpretation of clinical microbiology data
Author(s)
Paul Turner
Andrew Fox-Lewis
Poojan Shrestha
David A.B. Dance
Tri Wangrangsimakul
Tomas Paul Cusack
Clare L. Ling
Jill Hopkins
Tamalee Roberts
Direk Limmathurotsakul
Ben S. Cooper
Susanna Dunachie
Catrin E. Moore
Christiane Dolecek
H. Rogier Van Doorn
Philippe J. Guerin
Nicholas P.J. Day
Elizabeth A. Ashley
Andrew Fox-Lewis
Poojan Shrestha
David A.B. Dance
Tri Wangrangsimakul
Tomas Paul Cusack
Clare L. Ling
Jill Hopkins
Tamalee Roberts
Direk Limmathurotsakul
Ben S. Cooper
Susanna Dunachie
Catrin E. Moore
Christiane Dolecek
H. Rogier Van Doorn
Philippe J. Guerin
Nicholas P.J. Day
Elizabeth A. Ashley
Abstract
© 2019 The Author(s). Background: There is a pressing need to understand better the extent and distribution of antimicrobial resistance on a global scale, to inform development of effective interventions. Collation of datasets for meta-analysis, mathematical modelling and temporo-spatial analysis is hampered by the considerable variability in clinical sampling, variable quality in laboratory practice and inconsistencies in antimicrobial susceptibility testing and reporting. Methods: The Microbiology Investigation Criteria for Reporting Objectively (MICRO) checklist was developed by an international working group of clinical and laboratory microbiologists, infectious disease physicians, epidemiologists and mathematical modellers. Results: In keeping with the STROBE checklist, but applicable to all study designs, MICRO defines items to be included in reports of studies involving human clinical microbiology data. It provides a concise and comprehensive reference for clinicians, researchers, reviewers and journals working on, critically appraising, and publishing clinical microbiology datasets. Conclusions: Implementation of the MICRO checklist will enhance the quality and scientific reporting of clinical microbiology data, increasing data utility and comparability to improve surveillance, grade data quality, facilitate meta-analyses and inform policy and interventions from local to global levels.